Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis_Chinese Journal of Evidence-Based Medicine

Authors：

WU Huiyi ¹ , LIU Ying ² , LAN Yajia ^1,3 ,  ZHONG Jiao ⁴

1. Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. West China School of Medicine and West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
3. Department of Occupational and Environmental Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;
4. Department of Osteoporosis, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding?author：

ZHONG Jiao, Email: 79170224@qq.com

Keywords：

China; Postmenopausal female; Osteoporosis; Prevalence; Meta-analysis

DOI：

10.7507/1672-2531.202204036

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To systematically review the prevalence of osteoporosis (OP) in Chinese postmenopausal females. Methods The CNKI, VIP, CBM, WanFang Data, PubMed, EMbase and The Cochrane Library databases were electronically searched to collect studies on the prevalence of OP in Chinese postmenopausal females from inception to March 17^th, 2022. Two reviewers independently screened the literature, extracted data and evaluated the risk of bias of the included studies. Meta-analysis was then performed using Stata 14.0 software. Results A total of 54 studies involving 96 391 cases and 41 651 confirmed OP patients were included. The meta-analysis results showed that the prevalence of OP in Chinese postmenopausal females was 38.8% (95%CI 34.1% to 43.5%). Subgroup analysis showed that the prevalence of OP was 31.7% (95%CI 16.6% to 48.6%) in females who had been menopausal for less than 5 years, 47.4% (95%CI 32.2% to 62.5%) for 5-9 years, 52.7% (95%CI 37.1% to 68.3%) for 10-14 years, 77.5% (95%CI 69.5% to 85.4%) for 15-19 years, and 78.3% (95%CI 56.3% to 100.0%) for more than 20 years. The rate was 16.2% (95%CI 28.8% to 37.2%) in under 50 years age group, 28.8% (95%CI 34.4% to 47.9%) for 50- years group, 41.1% (95%CI 34.4% to 47.9%) for 60- years group, 55.3% (95%CI 45.8% to 64.8%) for 70- years group, 82.0% (95%CI 76.1% to 87.9%) for 80- years group. The prevalence in different regions was between 31.0% and 43.5%, which was lowest in the northeast (31.0%, 95%CI 26.3% to 51.4%) and highest in the northwest (43.5%, 95%CI 22.3% to 64.7%). According to the year of publication, the rate was 43.9% (95%CI 15.7% to 72.0%) from 1997 to 2009 and 38.2% (95%CI 33.8% to 42.5%) from 2010 to 2021. The prevalence of OP was 24.9% (95%CI 20.5% to 29.3%) in postmenopausal females with no birth or 1 birth, and 45.0% (95%CI 37.0% to 53.0%) in females with 2 or more births. Conclusion The prevalence of OP in Chinese postmenopausal females is relatively high. Due to the limited quantity and quality of the included studies, more high-quality studies are needed to verify the above conclusion.

Citation： WU Huiyi, LIU Ying, LAN Yajia, ZHONG Jiao. Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis. Chinese Journal of Evidence-Based Medicine, 2022, 22(8): 882-890. doi: 10.7507/1672-2531.202204036 Copy

1.	Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol, 2006, 194(Suppl 2): S3-11.
2.	中華醫學會骨質疏松和骨礦鹽疾病分會. 原發性骨質疏松癥診療指南(2017版). 中華骨質疏松和骨礦鹽疾病雜志, 2017, 10(5): 413-444.
3.	Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci, 2013, 68(10): 1243-1251.
4.	Wang L, Yu W, Yin X, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open, 2021, 4(8): e2121106.
5.	薛昊罡, 冷冰, 馬恩元, 等. 吉林市絕經后女性骨質疏松發病情況調查. 現代預防醫學, 2011, 38(20): 4135-4137.
6.	賀麗英, 孫蘊, 要文娟, 等. 2010-2016年中國老年人骨質疏松癥患病率Meta分析. 中國骨質疏松雜志, 2016, 22(12): 1590-1596.
7.	朱潔云, 高敏, 宋秋韻, 等. 中國老年人骨質疏松癥患病率的Meta分析. 中國全科醫學, 2022, 25(3): 346-353.
8.	曾憲濤, 劉慧, 陳曦, 等. Meta分析系列之四: 觀察性研究的質量評價工具. 中國循證心血管醫學雜志, 2012, 4(4): 297-299.
9.	安永東, 蔡興魁, 楊英, 等. 甘肅省臨夏地區絕經女性和老年男性骨質疏松流行病學調查及相關危險因素分析. 臨床醫藥文獻電子雜志, 2017, 4(92): 18187-18188.
10.	劉順智, 顏虹, 許鵬, 等. 西安市城區絕經后婦女骨密度與女性生理因素的相關性. 西安交通大學學報(醫學版), 2008, 29(1): 106-109.
11.	馬先富, 黃振武, 楊曉光, 等. 基于logistic模型對影響絕經期婦女骨質疏松癥的動物性飲食因素研究. 中國衛生統計, 2012, 29(2): 206-209, 213.
12.	王亞南, 侯欽午, 蔡燕明, 等. 絕經后女性不同部位骨密度檢測結果分析. 中國初級衛生保健, 2021, 35(11): 59-61.
13.	許衛東, 王濤, 沈江. 德清地區絕經期女性骨質疏松患病情況及其影響因素分析. 中國婦幼保健, 2020, 35(10): 1870-1873.
14.	Li S, Zhan J, Wang Y, et al. Association between renal function and bone mineral density in healthy postmenopausal Chinese women. BMC Endocr Disord, 2019, 19(1): 146.
15.	Lo SS. Bone health status of postmenopausal Chinese women. Hong Kong Med J, 2015, 21(6): 536-541.
16.	Ma Y, Li X, Zhang H, et al. Serum myostatin in central south Chinese postmenopausal women: relationship with body composition, lipids and bone mineral density. Endocr Res, 2016, 41(3): 223-228.
17.	黃定貴, 黃國秀, 閉應洲, 等. 南寧地區20899名壯族, 漢族正常人群峰值骨量和年齡相關骨丟失的臨床意義. 中國骨質疏松雜志, 2017, 23(11): 1507-1511.
18.	龍貴平, 王茹. 健康體檢骨密度測定4856例分析. 中國保健營養(中旬刊), 2012, (8): 394-394.
19.	彭茸, 張海燕, 周文正, 等. 重慶市2805例健康女性DXA法骨密度現況分析. 重慶醫科大學學報, 2019, 44(3): 356-359.
20.	宋衛紅, 李夢陽. 郴州市社區女性骨骼健康現狀調查研究. 湘南學院學報(醫學版), 2010, 12(1): 45-47.
21.	Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr, 2006, 83(1): 146-154.
22.	Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin, 2018, 39(4): 626-632.
23.	蔡程芳, 淦細紅, 陳和珍, 等. 溫州地區絕經后老年女性骨質疏松的患病率及其危險因素分析. 全科醫學臨床與教育, 2018, 16(4): 388-391, 413.
24.	陳俠, 陳琰琰, 林仲可. 絕經后老年女性骨質疏松與肌肉力量和肌肉含量的相關性研究. 護士進修雜志, 2019, 34(3): 207-210.
25.	程國鈞, 袁藝, 劉建立, 等. 北京市城區1400例婦女腰椎骨量與年齡和絕經的關系. 中華婦產科雜志, 1997, 32(9): 532-534.
26.	顧巧萍, 吳麗平, 孫微. 絕經后骨質疏松癥的患病率及危險因素研究. 中國婦幼保健, 2020, 35(22): 4158-4162.
27.	葉竹, 黃宏興, 付豐平, 等. 廣東省女性絕經后原發性骨質疏松癥調查分析. 中國骨質疏松雜志, 2012, 18(4): 344-346, 353.
28.	蔣紅巖, 申浩, 魏戌, 等. 北京市長辛店地區絕經后女性骨量狀態與骨代謝相關指標的關系. 中華骨質疏松和骨礦鹽疾病雜志, 2021, 14(2): 148-152.
29.	蔣燕飛. 女性絕經后發生骨質疏松癥的危險因素及其預防措施分析. 中國婦幼保健, 2021, 36(12): 2857-2859.
30.	李茂蓉, 黃薇, 歐小虹, 等. 絕經后非糖尿病婦女骨質疏松癥影響因素的Logistic回歸和ROC曲線分析. 中國骨質疏松雜志, 2016, 22(5): 540-544.
31.	梁莉, 馬子涵, 楊來虎, 等. 甘肅省蘭州地區中老年女性骨密度現狀調查及危險因素分析. 中國骨質疏松雜志, 2020, 26(11): 1685-1688.
32.	林彥杰, 李勇峰, 王輝輝. 非糖尿病女性絕經后骨質疏松發生率及其獨立危險因素分析. 中國民康醫學, 2017, 29(19): 19-21.
33.	羅采南, 石亞妹, 米克拉依, 等. 烏魯木齊城市和農村絕經后婦女血清維生素D與骨質疏松狀況調查. 中國骨質疏松雜志, 2018, 24(7): 940-943.
34.	馬曉慶, 司廣新, 王倩. 濟寧市健康體檢人群>50歲男性和絕經后女性骨質疏松及維生素D水平分析. 社區醫學雜志, 2020, 18(1): 20-23.
35.	楊華, 程昌志, 羅遠國, 等. 廣西地區絕經后婦女骨密度影響因素分析. 西部醫學, 2014, 26(11): 1504-1506.
36.	楊永碧. 絕經期女性骨質疏松及其影響因素. 中國老年學雜志, 2014, (11): 3176-3177, 3178.
37.	袁園, 周燕清, 於元. 咖啡飲品對絕經女性骨質疏松防治的影響. 中國婦幼保健, 2016, 31(19): 3990-3992.
38.	Chai H, Ge J, Li L, et al. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord, 2021, 22(1): 253.
39.	Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporosis, 2017, 12(1): 50.
40.	Li XS, Zhang JR, Meng SY, et al. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab, 2012, 30(6): 660-665.
41.	Sheng Z, Xu K, Ou Y, et al. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf), 2011, 74(3): 319-324.
42.	Zhao YX, Song YW, Zhang L, et al. Association between bile acid metabolism and bone mineral density in postmenopausal women. Clinics (Sao Paulo), 2020, 75: e1486.
43.	王劍, 魯敏, 孫官文, 等. 呼和浩特地區40~65歲中老年女性骨質疏松癥的流行現狀及相關因素分析. 中國醫藥, 2020, 15(4): 601-605.
44.	張珍珍, 李李. 皖北地區40~65歲女性骨質疏松的危險因素調查. 中國老年學雜志, 2017, 37(8): 2042-2045.
45.	曾玉紅, 劉峰, 張斌, 等. 2964例女性原發性骨質疏松檢出率分析. 中華老年醫學雜志, 2007, 26(9): 704-705.
46.	丘紅, 曾玉紅, 閆富梅, 等. 女性原發性骨質疏松患病率及易患因素的初步研究. 中國煤炭工業醫學雜志, 2008, 11(6): 831-832.
47.	王俊, 王雪君, 方貞. 城區中老年女性骨質疏松影響因素分析. 中國慢性病預防與控制, 2017, 25(4): 273-276.
48.	毛未賢, 張萌萌, 馬倩倩, 等. 長春地區女性骨密度與年齡、絕經年限、體重指數的相關性研究. 中國骨質疏松雜志, 2016, 22(9): 1083-1086.
49.	He Y, Huang J, Jiang G, et al. Menarche age exceed 17 years and menopausal age smaller than 48 years may affect prevalence of osteoporosis for Chinese women. Arch Osteoporos, 2021, 16(1): 123.
50.	郭華平, 郁嫣嫣, 陳文華, 等. 絕經后骨質疏松癥發病相關危險因素分析及預防措施探討. 中國康復醫學雜志, 2011, 26(5): 424-428.
51.	毛小明. 絕經婦女骨密度, 肌肉脂肪含量與骨質疏松的關系. 齊齊哈爾醫學院學報, 2017, 38(20): 2436-2438.
52.	秦寶瑩, 顧本進, 湯美秀. 江蘇地區3年間絕經女性患骨質疏松癥影響因素分析. 臨床軍醫雜志, 2019, 47(6): 634-635, 637.
53.	談佳, 向和東, 覃素嬌, 等. 廣西壯族與漢族絕經后女性骨密度及骨質疏松癥患病率調查分析. 廣東醫學, 2018, 39(11): 1723-1725.
54.	覃素嬌, 羅穎華, 羅珍玉, 等. 廣西南寧市區絕經后女性骨質疏松癥流行情況及相關因素研究. 中國骨質疏松雜志, 2017, 23(7): 942-946.
55.	田利民, 楊睿斐, 魏蓮花, 等. 甘肅省絕經女性和老年男性骨質疏松流行病學調查及相關影響因素分析. 中華骨質疏松和骨礦鹽疾病雜志, 2018, 11(2): 142-148.
56.	王奔, 林乾, 韓棟, 等. 絕經后女性骨質疏松危險因素分析. 中國慢性病預防與控制, 2021, 29(7): 510-513.
57.	郭貴華, 李穎, 彭玉蘭, 等. 黔南地區農村≥40歲女性居民絕經后骨質疏松癥患病率調查. 飲食保健, 2021, (5): 274-275.
58.	李漫馥, 齊俊婷, 張靖唯. 葫蘆島市龍港區絕經后婦女骨質疏松癥患病現狀及其影響因素. 中國衛生工程學, 2021, 20(5): 763-765.
59.	劉付國杰, 朱國華, 李裕漢. 茂名地區絕經后女性骨密度調查及不同部位檢出率研究. 中國醫學創新, 2017, 14(13): 72-75.
60.	余建國, 姚安晉, 張東, 等. 絕經后骨質疏松癥腰椎骨密度研究. 實用放射學雜志, 2000, 16(1): 35-36.
61.	Li S, Guo H, Liu Y, et al. Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women. Clin Endocrinol (Oxf), 2015, 82(1): 53-58.
62.	Eghbali T, Abdi K, Nazari M, et al. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord, 2022, 15: 11795441211072471.
63.	Baccaro LF, Conde DM, Costa-Paiva L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging, 2015, 10: 583-591.
64.	Thulkar J, Singh S, Sharma S, et al. Preventable risk factors for osteoporosis in postmenopausal women: systematic review and meta-analysis. J Midlife Health, 2016, 7(3): 108-113.
65.	胡偉雄, 林涌鵬, 饒思遠, 等. 814例絕經后女性初潮年齡, 絕經年齡及月經維持年限與骨質疏松癥相關性研究. 中國骨質疏松雜志, 2020, 26(9): 1257-1261.

1. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol, 2006, 194(Suppl 2): S3-11.
2. 中華醫學會骨質疏松和骨礦鹽疾病分會. 原發性骨質疏松癥診療指南(2017版). 中華骨質疏松和骨礦鹽疾病雜志, 2017, 10(5): 413-444.
3. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci, 2013, 68(10): 1243-1251.
4. Wang L, Yu W, Yin X, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open, 2021, 4(8): e2121106.
5. 薛昊罡, 冷冰, 馬恩元, 等. 吉林市絕經后女性骨質疏松發病情況調查. 現代預防醫學, 2011, 38(20): 4135-4137.
6. 賀麗英, 孫蘊, 要文娟, 等. 2010-2016年中國老年人骨質疏松癥患病率Meta分析. 中國骨質疏松雜志, 2016, 22(12): 1590-1596.
7. 朱潔云, 高敏, 宋秋韻, 等. 中國老年人骨質疏松癥患病率的Meta分析. 中國全科醫學, 2022, 25(3): 346-353.
8. 曾憲濤, 劉慧, 陳曦, 等. Meta分析系列之四: 觀察性研究的質量評價工具. 中國循證心血管醫學雜志, 2012, 4(4): 297-299.
9. 安永東, 蔡興魁, 楊英, 等. 甘肅省臨夏地區絕經女性和老年男性骨質疏松流行病學調查及相關危險因素分析. 臨床醫藥文獻電子雜志, 2017, 4(92): 18187-18188.
10. 劉順智, 顏虹, 許鵬, 等. 西安市城區絕經后婦女骨密度與女性生理因素的相關性. 西安交通大學學報(醫學版), 2008, 29(1): 106-109.
11. 馬先富, 黃振武, 楊曉光, 等. 基于logistic模型對影響絕經期婦女骨質疏松癥的動物性飲食因素研究. 中國衛生統計, 2012, 29(2): 206-209, 213.
12. 王亞南, 侯欽午, 蔡燕明, 等. 絕經后女性不同部位骨密度檢測結果分析. 中國初級衛生保健, 2021, 35(11): 59-61.
13. 許衛東, 王濤, 沈江. 德清地區絕經期女性骨質疏松患病情況及其影響因素分析. 中國婦幼保健, 2020, 35(10): 1870-1873.
14. Li S, Zhan J, Wang Y, et al. Association between renal function and bone mineral density in healthy postmenopausal Chinese women. BMC Endocr Disord, 2019, 19(1): 146.
15. Lo SS. Bone health status of postmenopausal Chinese women. Hong Kong Med J, 2015, 21(6): 536-541.
16. Ma Y, Li X, Zhang H, et al. Serum myostatin in central south Chinese postmenopausal women: relationship with body composition, lipids and bone mineral density. Endocr Res, 2016, 41(3): 223-228.
17. 黃定貴, 黃國秀, 閉應洲, 等. 南寧地區20899名壯族, 漢族正常人群峰值骨量和年齡相關骨丟失的臨床意義. 中國骨質疏松雜志, 2017, 23(11): 1507-1511.
18. 龍貴平, 王茹. 健康體檢骨密度測定4856例分析. 中國保健營養(中旬刊), 2012, (8): 394-394.
19. 彭茸, 張海燕, 周文正, 等. 重慶市2805例健康女性DXA法骨密度現況分析. 重慶醫科大學學報, 2019, 44(3): 356-359.
20. 宋衛紅, 李夢陽. 郴州市社區女性骨骼健康現狀調查研究. 湘南學院學報(醫學版), 2010, 12(1): 45-47.
21. Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr, 2006, 83(1): 146-154.
22. Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin, 2018, 39(4): 626-632.
23. 蔡程芳, 淦細紅, 陳和珍, 等. 溫州地區絕經后老年女性骨質疏松的患病率及其危險因素分析. 全科醫學臨床與教育, 2018, 16(4): 388-391, 413.
24. 陳俠, 陳琰琰, 林仲可. 絕經后老年女性骨質疏松與肌肉力量和肌肉含量的相關性研究. 護士進修雜志, 2019, 34(3): 207-210.
25. 程國鈞, 袁藝, 劉建立, 等. 北京市城區1400例婦女腰椎骨量與年齡和絕經的關系. 中華婦產科雜志, 1997, 32(9): 532-534.
26. 顧巧萍, 吳麗平, 孫微. 絕經后骨質疏松癥的患病率及危險因素研究. 中國婦幼保健, 2020, 35(22): 4158-4162.
27. 葉竹, 黃宏興, 付豐平, 等. 廣東省女性絕經后原發性骨質疏松癥調查分析. 中國骨質疏松雜志, 2012, 18(4): 344-346, 353.
28. 蔣紅巖, 申浩, 魏戌, 等. 北京市長辛店地區絕經后女性骨量狀態與骨代謝相關指標的關系. 中華骨質疏松和骨礦鹽疾病雜志, 2021, 14(2): 148-152.
29. 蔣燕飛. 女性絕經后發生骨質疏松癥的危險因素及其預防措施分析. 中國婦幼保健, 2021, 36(12): 2857-2859.
30. 李茂蓉, 黃薇, 歐小虹, 等. 絕經后非糖尿病婦女骨質疏松癥影響因素的Logistic回歸和ROC曲線分析. 中國骨質疏松雜志, 2016, 22(5): 540-544.
31. 梁莉, 馬子涵, 楊來虎, 等. 甘肅省蘭州地區中老年女性骨密度現狀調查及危險因素分析. 中國骨質疏松雜志, 2020, 26(11): 1685-1688.
32. 林彥杰, 李勇峰, 王輝輝. 非糖尿病女性絕經后骨質疏松發生率及其獨立危險因素分析. 中國民康醫學, 2017, 29(19): 19-21.
33. 羅采南, 石亞妹, 米克拉依, 等. 烏魯木齊城市和農村絕經后婦女血清維生素D與骨質疏松狀況調查. 中國骨質疏松雜志, 2018, 24(7): 940-943.
34. 馬曉慶, 司廣新, 王倩. 濟寧市健康體檢人群>50歲男性和絕經后女性骨質疏松及維生素D水平分析. 社區醫學雜志, 2020, 18(1): 20-23.
35. 楊華, 程昌志, 羅遠國, 等. 廣西地區絕經后婦女骨密度影響因素分析. 西部醫學, 2014, 26(11): 1504-1506.
36. 楊永碧. 絕經期女性骨質疏松及其影響因素. 中國老年學雜志, 2014, (11): 3176-3177, 3178.
37. 袁園, 周燕清, 於元. 咖啡飲品對絕經女性骨質疏松防治的影響. 中國婦幼保健, 2016, 31(19): 3990-3992.
38. Chai H, Ge J, Li L, et al. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord, 2021, 22(1): 253.
39. Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporosis, 2017, 12(1): 50.
40. Li XS, Zhang JR, Meng SY, et al. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab, 2012, 30(6): 660-665.
41. Sheng Z, Xu K, Ou Y, et al. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf), 2011, 74(3): 319-324.
42. Zhao YX, Song YW, Zhang L, et al. Association between bile acid metabolism and bone mineral density in postmenopausal women. Clinics (Sao Paulo), 2020, 75: e1486.
43. 王劍, 魯敏, 孫官文, 等. 呼和浩特地區40~65歲中老年女性骨質疏松癥的流行現狀及相關因素分析. 中國醫藥, 2020, 15(4): 601-605.
44. 張珍珍, 李李. 皖北地區40~65歲女性骨質疏松的危險因素調查. 中國老年學雜志, 2017, 37(8): 2042-2045.
45. 曾玉紅, 劉峰, 張斌, 等. 2964例女性原發性骨質疏松檢出率分析. 中華老年醫學雜志, 2007, 26(9): 704-705.
46. 丘紅, 曾玉紅, 閆富梅, 等. 女性原發性骨質疏松患病率及易患因素的初步研究. 中國煤炭工業醫學雜志, 2008, 11(6): 831-832.
47. 王俊, 王雪君, 方貞. 城區中老年女性骨質疏松影響因素分析. 中國慢性病預防與控制, 2017, 25(4): 273-276.
48. 毛未賢, 張萌萌, 馬倩倩, 等. 長春地區女性骨密度與年齡、絕經年限、體重指數的相關性研究. 中國骨質疏松雜志, 2016, 22(9): 1083-1086.
49. He Y, Huang J, Jiang G, et al. Menarche age exceed 17 years and menopausal age smaller than 48 years may affect prevalence of osteoporosis for Chinese women. Arch Osteoporos, 2021, 16(1): 123.
50. 郭華平, 郁嫣嫣, 陳文華, 等. 絕經后骨質疏松癥發病相關危險因素分析及預防措施探討. 中國康復醫學雜志, 2011, 26(5): 424-428.
51. 毛小明. 絕經婦女骨密度, 肌肉脂肪含量與骨質疏松的關系. 齊齊哈爾醫學院學報, 2017, 38(20): 2436-2438.
52. 秦寶瑩, 顧本進, 湯美秀. 江蘇地區3年間絕經女性患骨質疏松癥影響因素分析. 臨床軍醫雜志, 2019, 47(6): 634-635, 637.
53. 談佳, 向和東, 覃素嬌, 等. 廣西壯族與漢族絕經后女性骨密度及骨質疏松癥患病率調查分析. 廣東醫學, 2018, 39(11): 1723-1725.
54. 覃素嬌, 羅穎華, 羅珍玉, 等. 廣西南寧市區絕經后女性骨質疏松癥流行情況及相關因素研究. 中國骨質疏松雜志, 2017, 23(7): 942-946.
55. 田利民, 楊睿斐, 魏蓮花, 等. 甘肅省絕經女性和老年男性骨質疏松流行病學調查及相關影響因素分析. 中華骨質疏松和骨礦鹽疾病雜志, 2018, 11(2): 142-148.
56. 王奔, 林乾, 韓棟, 等. 絕經后女性骨質疏松危險因素分析. 中國慢性病預防與控制, 2021, 29(7): 510-513.
57. 郭貴華, 李穎, 彭玉蘭, 等. 黔南地區農村≥40歲女性居民絕經后骨質疏松癥患病率調查. 飲食保健, 2021, (5): 274-275.
58. 李漫馥, 齊俊婷, 張靖唯. 葫蘆島市龍港區絕經后婦女骨質疏松癥患病現狀及其影響因素. 中國衛生工程學, 2021, 20(5): 763-765.
59. 劉付國杰, 朱國華, 李裕漢. 茂名地區絕經后女性骨密度調查及不同部位檢出率研究. 中國醫學創新, 2017, 14(13): 72-75.
60. 余建國, 姚安晉, 張東, 等. 絕經后骨質疏松癥腰椎骨密度研究. 實用放射學雜志, 2000, 16(1): 35-36.
61. Li S, Guo H, Liu Y, et al. Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women. Clin Endocrinol (Oxf), 2015, 82(1): 53-58.
62. Eghbali T, Abdi K, Nazari M, et al. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord, 2022, 15: 11795441211072471.
63. Baccaro LF, Conde DM, Costa-Paiva L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging, 2015, 10: 583-591.
64. Thulkar J, Singh S, Sharma S, et al. Preventable risk factors for osteoporosis in postmenopausal women: systematic review and meta-analysis. J Midlife Health, 2016, 7(3): 108-113.
65. 胡偉雄, 林涌鵬, 饒思遠, 等. 814例絕經后女性初潮年齡, 絕經年齡及月經維持年限與骨質疏松癥相關性研究. 中國骨質疏松雜志, 2020, 26(9): 1257-1261.

Chinese Journal of Evidence-Based Medicine

Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content